loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Dexamethasone Acetate.

Menu
$ API Ref.Price (USD/KG) : 698Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AbbVie Corporation

02 1Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
Luxepack
Not Confirmed

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2429998

Filing Date : 2001-11-28

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2021-11-28

Date Granted : 2012-01-17

Abbvie CB

02

arrow
Luxepack
Not Confirmed

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2414680

Filing Date : 2001-07-03

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2021-07-03

Date Granted : 2007-09-18

Abbvie CB

03

arrow
Luxepack
Not Confirmed

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2512315

Filing Date : 2004-01-07

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2024-01-07

Date Granted : 2008-12-30

Abbvie CB